Overview

EZH


'EZH' can also refer to...

EZH

PRC2/EED-EZH complexes

PRC2/EED-EZH complexes

Targeting histone methyltransferase EZH2 as cancer treatment

MB-72THE ROLE OF EZH2 IN MEDULLOBLASTOMA

TR-01Ezh2, A NOVEL TARGET IN TREATMENT OF MEDULLOBLASTOMA

TO034POLYCYSTIN-1 REGULATES EZH2 EXPRESSION THROUGH THE CAMP/PKA PATHWAY AND EZH2 INHIBITION DELAYS ADPKD PROGRESSION

13PEXPRESSION OF IRAK-1 AND EZH-2 IN IMPRINTS OF NSCLC AND PRENEOPLASTIC LESIONS

An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients

EZH2 polymorphism and benefit from bevacizumab in colorectal cancer: another piece to the puzzle

DISTINCT AND SEPARABLE ROLES FOR HISTONE METHYLTRANSFERASE EZH2 IN NEUROGENIC ASTROCYTES

Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells

Survival of skin cancer stem cells requires the Ezh2 polycomb group protein

PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression

NIPP1 maintains EZH2 phosphorylation and promoter occupancy at proliferation-related target genes

EXTH-37. TARGETING GLIOMA STEM CELLS THROUGH COMBINED BMI1 AND EZH2 INHIBITION

L07.04PRECLINICAL CHARACTERIZATION OF E7438, A POTENT, SELECTIVE EZH2 INHIBITOR WITH ROBUST ANTITUMOR ACTIVITY AGAINST EZH2 MUTATED NHL XENOGRAFTS IN MICE

3P17-Demethoxygeldanamycin inhibits self-renewal of breast cancer stem cells through EZH2/c-Myc/Bmi1 pathway

High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer

 

More Like This

Show all results sharing this subject:

  • Medicine and Health

GO

Show Summary Details

Quick Reference

Polycomb group (PcG) proteins (enhancer of zeste homologues) that are the catalytic component of the polycomb repressive complexes (PRC2/EED-EZH complexes), histone-lysine N-methyltransferases, EC 2.1.1.43). EZH2 (746 aa) is a marker for aggressiveness in prostate and breast carcinoma.

Subjects: Medicine and Health.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.